易明医药
(002826)
| 流通市值：35.72亿 | | | 总市值：37.22亿 |
| 流通股本：1.83亿 | | | 总股本：1.91亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 433,557,153.78 | 537,664,815.13 | 297,683,078.19 | 265,948,740.21 |
| 交易性金融资产 | 200,000,000 | - | 280,000,000 | 250,000,000 |
| 应收票据及应收账款 | 25,771,388.36 | 29,534,633.32 | 45,589,434.98 | 44,957,157.84 |
| 其中：应收票据 | 3,744,340 | 16,790,433.34 | 738,570 | 91,592 |
| 应收账款 | 22,027,048.36 | 12,744,199.98 | 44,850,864.98 | 44,865,565.84 |
| 预付款项 | 1,762,232.53 | 1,090,324.9 | 5,635,784.05 | 2,903,743.44 |
| 其他应收款合计 | 2,292,107.11 | 2,618,801.29 | 2,726,644.07 | 2,865,845.18 |
| 存货 | 57,431,057.36 | 59,782,766.19 | 38,722,725.8 | 48,929,388.73 |
| 一年内到期的非流动资产 | 2,386,824.89 | 2,424,562.07 | - | - |
| 其他流动资产 | 73,528.76 | 566,359.06 | 1,920,309.2 | 170,368.66 |
| 流动资产合计 | 723,274,292.79 | 633,682,261.96 | 672,277,976.29 | 615,775,244.06 |
| 非流动资产: | | | | |
| 长期应收款 | 9,422,615.28 | 9,344,055.16 | 11,671,140.3 | 11,534,850.4 |
| 其他非流动金融资产 | 3,479,978.48 | 3,534,999.09 | 3,573,573.88 | 3,600,279.49 |
| 固定资产 | 327,509,990.04 | 331,295,695.64 | 332,127,929.27 | 335,878,084.4 |
| 在建工程 | - | - | 1,648,793.87 | 730,303.45 |
| 无形资产 | 19,005,187.21 | 19,202,577.32 | 19,176,327.91 | 19,362,679.28 |
| 商誉 | 16,668,928.89 | 16,668,928.89 | 16,668,928.89 | 16,668,928.89 |
| 递延所得税资产 | 3,865,859.31 | 3,839,106.67 | 1,628,889.72 | 1,704,924.1 |
| 其他非流动资产 | 64,000 | 106,750 | - | - |
| 非流动资产合计 | 380,016,559.21 | 383,992,112.77 | 386,495,583.84 | 389,480,050.01 |
| 资产总计 | 1,103,290,852 | 1,017,674,374.73 | 1,058,773,560.13 | 1,005,255,294.07 |
| 流动负债: | | | | |
| 短期借款 | - | 11,259,529.05 | 26,769,048.65 | 44,907,378.35 |
| 应付票据及应付账款 | 145,225,202.24 | 105,834,727.82 | 139,047,524.67 | 114,056,502.66 |
| 应付账款 | 145,225,202.24 | 105,834,727.82 | 139,047,524.67 | 114,056,502.66 |
| 合同负债 | 5,415,643.01 | 1,950,059.15 | 1,354,519.08 | 561,865.89 |
| 应付职工薪酬 | 26,417,220.73 | 25,660,495.33 | 17,206,269.9 | 12,757,689.57 |
| 应交税费 | 11,880,786.03 | 9,316,643.82 | 20,381,268.27 | 9,222,932.48 |
| 其他应付款合计 | 70,816,562.28 | 42,405,830.75 | 46,520,558.53 | 47,499,891.53 |
| 其他流动负债 | 704,033.59 | 253,507.69 | 176,087.48 | 73,042.56 |
| 流动负债合计 | 260,459,447.88 | 196,680,793.61 | 251,455,276.58 | 229,079,303.04 |
| 非流动负债: | | | | |
| 递延收益 | 4,811,175.48 | 4,970,040.93 | 5,171,406.09 | 5,372,771.55 |
| 非流动负债合计 | 4,811,175.48 | 4,970,040.93 | 5,171,406.09 | 5,372,771.55 |
| 负债合计 | 265,270,623.36 | 201,650,834.54 | 256,626,682.67 | 234,452,074.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 190,677,750 | 190,677,750 | 190,677,750 | 190,677,750 |
| 资本公积 | 244,083,206.49 | 232,644,488.45 | 229,463,954 | 235,764,877.92 |
| 减:库存股 | 57,346,995.35 | 48,147,160.64 | 48,147,160.64 | 48,147,160.64 |
| 其他综合收益 | -756,108.55 | -102,466.31 | 407,752.59 | 762,043.91 |
| 专项储备 | 9,250,685.78 | 8,487,608.83 | 8,098,739.21 | 7,551,356.71 |
| 盈余公积 | 27,780,809 | 27,780,809 | 21,861,741.5 | 21,861,741.5 |
| 未分配利润 | 424,330,881.27 | 404,682,510.86 | 399,784,100.8 | 355,577,973.54 |
| 归属于母公司股东权益合计 | 838,020,228.64 | 816,023,540.19 | 802,146,877.46 | 764,048,582.94 |
| 少数股东权益 | - | - | - | 6,754,636.54 |
| 股东权益合计 | 838,020,228.64 | 816,023,540.19 | 802,146,877.46 | 770,803,219.48 |
| 负债和股东权益合计 | 1,103,290,852 | 1,017,674,374.73 | 1,058,773,560.13 | 1,005,255,294.07 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-29 | 2025-08-15 |
| 审计意见(境内) | | 标准无保留意见 | | |